Ascendis Pharma Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	266.72	51.17	7.78	6.95	13.38	10.58	1.53	4.61	8.12	13.98	Upgrade
Revenue Growth (YoY)	421.20%	557.93%	11.87%	-48.01%	26.41%	591.57%	-66.78%	-43.26%	-41.94%	-31.48%	Upgrade
Cost of Revenue	44.4	12.14	3.52	0	0	0	0	0	0	0	Upgrade
Gross Profit	222.32	39.04	4.26	6.95	13.38	10.58	1.53	4.61	8.12	13.98	Upgrade
Selling, General & Admin	264.41	221.23	160.18	76.67	48.47	25.06	13.48	11.5	9.42	6.27	Upgrade
Research & Development	413.45	379.62	295.87	260.9	191.62	140.28	99.59	66.02	40.53	19.7	Upgrade
Operating Expenses	677.86	600.85	456.05	337.57	240.09	165.34	113.07	77.53	49.94	25.97	Upgrade
Operating Income	-455.54	-561.81	-451.79	-330.62	-226.72	-154.76	-111.54	-72.92	-41.83	-11.99	Upgrade
Interest Expense / Income	44.07	50.49	3.91	80.84	1.22	0.13	13.76	3.11	2.8	0.23	Upgrade
Other Expense / Income	-25.46	-34.48	-71.76	7.71	-9.69	-24.39	-0.92	-7.3	-11.05	-1.88	Upgrade
Pretax Income	-474.14	-577.82	-383.94	-419.17	-218.25	-130.49	-124.37	-68.73	-33.57	-10.34	Upgrade
Income Tax	7.3	5.38	-0.37	-0.22	-0.23	-0.39	-0.48	-0.23	-0.65	-0.68	Upgrade
Net Income	-481.45	-583.19	-383.58	-418.96	-218.02	-130.1	-123.9	-68.51	-32.92	-9.66	Upgrade
Shares Outstanding (Basic)	56	56	55	51	47	41	34	27	24	11	Upgrade
Shares Outstanding (Diluted)	56	56	55	51	47	41	34	27	24	11	Upgrade
Shares Change	0.38%	2.37%	8.21%	8.84%	13.20%	22.18%	26.58%	11.77%	108.35%	-11.06%	Upgrade
EPS (Basic)	-8.55	-10.40	-7.00	-8.28	-4.69	-3.17	-3.68	-2.58	-1.39	-0.85	Upgrade
EPS (Diluted)	-8.55	-10.40	-7.00	-8.28	-4.69	-3.17	-3.68	-2.58	-1.39	-0.85	Upgrade
Free Cash Flow	-469.75	-500.65	-441.88	-288.05	-181.1	-141.45	-96.04	-60.85	-44.51	-18.81	Upgrade
Free Cash Flow Per Share	-8.35	-8.93	-8.07	-5.69	-3.89	-3.44	-2.86	-2.29	-1.87	-1.65	Upgrade
Gross Margin	83.36%	76.28%	54.71%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-170.79%	-1097.85%	-5808.59%	-4755.07%	-1695.10%	-1462.59%	-7290.26%	-1583.15%	-515.21%	-85.74%	Upgrade
Profit Margin	-180.51%	-1139.63%	-4931.56%	-6025.53%	-1630.03%	-1229.53%	-8097.84%	-1487.30%	-405.54%	-69.07%	Upgrade
Free Cash Flow Margin	-176.12%	-978.33%	-5681.19%	-4142.76%	-1353.98%	-1336.83%	-6277.12%	-1321.12%	-548.23%	-134.51%	Upgrade
EBITDA	-411.17	-509.37	-364.64	-328.88	-210.34	-129.48	-109.88	-64.94	-30.22	-9.61	Upgrade
EBITDA Margin	-154.16%	-995.37%	-4688.12%	-4730.10%	-1572.64%	-1223.74%	-7181.96%	-1409.97%	-372.25%	-68.71%	Upgrade
Depreciation & Amortization	18.91	17.96	15.39	9.45	6.69	0.88	0.73	0.68	0.56	0.5	Upgrade
EBIT	-430.08	-527.33	-380.03	-338.33	-217.03	-130.36	-110.62	-65.62	-30.78	-10.11	Upgrade
EBIT Margin	-161.25%	-1030.46%	-4886.00%	-4865.99%	-1622.65%	-1232.06%	-7229.93%	-1424.66%	-379.12%	-72.32%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).